Home / Tag Archives: medical countermeasure

Tag Archives: medical countermeasure

Battelle Teams With Nanotherapeutics for DoD Program on CBRN Medical Countermeasures

TYSONS CORNER, VA, April 7, 2017 — Battelle has partnered with Nanotherapeutics in efforts to research, develop, test and evaluate medical countermeasures for the U.S. military against chemical, biological, radiological and nuclear threats, ExecutiveBiz reported Thursday. The team aims to address Defense Department requirements for vaccines, post-exposure prophylactics and therapeutics to protect deployed military personnel …

Read More »

CSRA’s DynPort Vaccine Company Gets Orphan Drug Designation on Plague Vaccine

TYSONS CORNER, VA, March 10, 2017 — A subsidiary of CSRA (NYSE: CSRA) has secured orphan drug status from the Food and Drug Administration on a plague vaccine it is developing as a potential pre-exposure prophlaxis treatment against Yersinia pestis infection, ExecutiveBiz reported Thursday. The company said Wednesday the designation enables DynPort Vaccine Company to …

Read More »